Can 40Hz Stimulation Affect Amyloid and Tau? Understanding the Alzheimer’s Research
Share
Can 40Hz stimulation affect amyloid and tau? This is one of the most closely studied questions in emerging research on gamma-frequency brain stimulation and Alzheimer's disease.
Over the past several years, researchers have investigated whether 40Hz light stimulation, auditory stimulation, or combined sensory stimulation can influence brain activity and biological processes associated with Alzheimer's disease—including amyloid beta (Aβ) and tau protein.
The results are intriguing, but they require careful interpretation.
Animal studies have reported substantial changes in amyloid burden and tau-related pathology. Early human studies have begun examining blood biomarkers such as amyloid beta and phosphorylated tau, with some encouraging preliminary findings. However, researchers have not yet established that 40Hz stimulation can remove Alzheimer's pathology or treat Alzheimer's disease.
So what does the science actually show?
Let's look at the evidence.
What Are Amyloid Beta and Tau?
Two proteins are particularly important in Alzheimer's disease research: amyloid beta and tau.
Amyloid Beta
Amyloid beta is a protein fragment that can accumulate in the brain and form plaques.
Amyloid plaques are one of the characteristic pathological features associated with Alzheimer's disease.
Researchers have therefore investigated whether interventions that alter brain activity could potentially influence:
-
Amyloid beta production
-
Amyloid aggregation
-
Amyloid clearance
-
Soluble amyloid levels
-
Amyloid plaque accumulation
This is one reason 40Hz stimulation and amyloid beta have become important research topics.
Tau Protein
Tau is a protein normally involved in maintaining the structure of neurons.
In Alzheimer's disease, abnormal forms of tau—including phosphorylated tau—can accumulate and form neurofibrillary tangles.
Researchers commonly study biomarkers such as:
-
p-tau181
-
p-tau217
-
Total tau
-
Tau pathology
Because amyloid and tau are both associated with Alzheimer's disease pathology, researchers are asking whether 40Hz gamma stimulation could influence either or both biological pathways.
Why Would 40Hz Stimulation Affect Amyloid or Tau?
The hypothesis begins with gamma oscillations.
Gamma rhythms are patterns of synchronized neural activity commonly measured in the approximately 30–100Hz range. Around 40Hz is one frequency that researchers have investigated extensively.
When visual or auditory stimuli are delivered at 40Hz, the brain can respond with activity synchronized to that frequency. This process is commonly described as gamma entrainment.
Researchers are investigating whether repeated gamma entrainment could influence biological processes beyond the immediate neural response.
A simplified research hypothesis looks like this:
40Hz sensory stimulation
↓
Gamma entrainment
↓
Changes in neural network activity
↓
Potential changes in cellular, vascular, immune, or clearance mechanisms
↓
Possible effects on amyloid and tau-related biomarkers
The important word is possible.
Several steps in this proposed pathway remain under investigation.
What Have Animal Studies Found?
Some of the strongest evidence connecting 40Hz stimulation with amyloid and tau comes from preclinical research.
In Alzheimer's disease mouse models, researchers have reported that gamma-frequency stimulation can influence several biological processes, including amyloid pathology, immune responses, synaptic function, and neuronal activity.
A 2025 review of 40Hz sensory stimulation summarized preclinical findings suggesting reductions in cerebral amyloid burden, effects on tau phosphorylation, and improvements in neural synchronization and memory performance in animal models.
These findings are scientifically important because they provide potential mechanisms that can be investigated in humans.
However, animal results are not the same as clinical evidence.
A treatment that changes amyloid or tau in an Alzheimer's mouse model does not automatically produce the same effect in people.
This distinction is especially important when evaluating claims about 40Hz light therapy for Alzheimer's disease.
How Could 40Hz Stimulation Potentially Influence Amyloid?
Researchers have proposed several mechanisms.
1. Neural Network Synchronization
One possibility is that gamma stimulation changes the synchronization of neural networks.
Neurons do not operate independently. Large populations of neurons continuously communicate through coordinated electrical activity.
40Hz sensory stimulation can produce measurable gamma-frequency responses in the brain.
Researchers are investigating whether repeated stimulation can influence downstream cellular and network processes.
2. Changes in Brain Immune Activity
Another area of interest is the activity of microglia, immune cells found in the brain.
Microglia participate in maintaining brain tissue and responding to cellular debris and pathological changes.
Preclinical research suggests that gamma stimulation may alter microglial activity and potentially influence processes involved in amyloid handling.
However, translating these mechanisms from animal models to human Alzheimer's disease remains an active research question.
3. Vascular and Clearance Mechanisms
Researchers have also investigated whether gamma stimulation could affect vascular activity and mechanisms involved in the movement and clearance of substances from brain tissue.
The relationship between neural activity, blood flow, and waste-clearance systems such as the glymphatic system has become an important area of neuroscience research.
Some reviews have identified 40Hz sensory stimulation as a potential way of influencing these processes, but the clinical significance for Alzheimer's disease remains uncertain.
What About Tau?
Amyloid is not the only target of interest.
Researchers are also investigating whether 40Hz stimulation may influence tau phosphorylation.
This is particularly interesting because tau pathology is strongly associated with neurodegeneration and cognitive decline in Alzheimer's disease.
Preclinical studies have reported changes in tau-related pathology following gamma-frequency stimulation. A recent review of the field summarized evidence suggesting that 40Hz sensory stimulation may inhibit tau phosphorylation in experimental Alzheimer's models.
But again, there is a major distinction:
Evidence that 40Hz stimulation affects tau in animal models does not prove that the same effect occurs in humans.
Human biomarker studies are therefore particularly important.
What Have Human Studies Found?
Human evidence is newer and considerably more limited.
One of the most interesting developments came from a 2026 longitudinal study of 40Hz light stimulation in people with Alzheimer's disease.
The study enrolled 14 participants. Eleven completed three months of stimulation, while six continued to six months for the final blood-biomarker analysis.
Researchers measured several biomarkers, including:
-
Amyloid beta oligomers
-
Aβ40
-
Aβ42
-
p-tau181
-
p-tau217
-
Neurofilament light chain
The researchers reported decreased amyloid-beta oligomers, increased Aβ42, and reductions in phosphorylated tau, which they interpreted as potentially consistent with neuroprotective or disease-modifying effects.
The study also reported that, after six months:
-
66.7% of participants showed decreased Aβ oligomers
-
66.7% showed an increased Aβ42/Aβ40 ratio
-
83.3% showed reduced plasma p-tau217
-
66.7% showed an increased Aβ42/p-tau181 ratio
These results are certainly interesting.
But the sample size is extremely small.
Only six participants contributed to the six-month biomarker analysis.
That means these findings should be viewed as preliminary evidence that warrants larger controlled trials, rather than proof that 40Hz light stimulation removes amyloid or tau in Alzheimer's disease.
Does Lower Blood Amyloid Mean Less Amyloid in the Brain?
Not necessarily.
This is an important distinction when interpreting biomarker studies.
Blood biomarkers can provide valuable information about Alzheimer's disease biology, but changes in blood concentrations do not automatically mean that amyloid plaques have been removed from the brain.
For example, researchers may measure:
Plasma Aβ40 / Aβ42
or
Plasma p-tau217
These biomarkers can provide information related to Alzheimer's pathology.
But they should not automatically be interpreted as direct measurements of the amount of amyloid plaque or tau tangles inside the brain.
More research using multiple methods—including imaging, cerebrospinal fluid measurements, blood biomarkers, and cognitive outcomes—can provide a stronger picture.
What Does the Latest Research Actually Prove?
This is where the distinction between promising research and proven treatment becomes important.
Current evidence suggests that:
40Hz stimulation can influence brain activity
Human studies have demonstrated that appropriately designed 40Hz sensory stimulation can produce measurable gamma-frequency entrainment.
Animal studies suggest biological effects
Preclinical Alzheimer's models have reported changes involving amyloid, tau, synaptic function, immune responses, and other biological pathways.
Early human studies are beginning to show biomarker signals
The 2026 longitudinal study reported exploratory changes in amyloid- and tau-related blood biomarkers after 40Hz light stimulation.
But clinical efficacy remains uncertain
A 2025 systematic review and meta-analysis of 11 studies involving 341 participants found that gamma-frequency auditory and visual stimulation was generally well tolerated and was associated with some structural brain changes. However, it did not find a statistically significant overall improvement in cognitive function or activities of daily living.
This is an important reality check.
The field has produced encouraging biological signals, but it has not yet established a definitive clinical benefit for Alzheimer's disease.
Why Are Researchers Still Studying 40Hz?
Because several different lines of evidence are pointing in the same general direction.
Researchers have observed:
-
Gamma entrainment in humans
-
Biological effects in animal models
-
Changes in neural connectivity
-
Potential effects on amyloid-related pathways
-
Potential effects on tau-related pathways
-
Changes in certain brain-structure measurements
-
Preliminary changes in blood biomarkers
-
Ongoing clinical trials
Together, these findings make 40Hz gamma stimulation an active area of neuroscience research.
But each type of evidence answers a different question.
| Evidence | What It Can Tell Us |
|---|---|
| Animal studies | Possible biological mechanisms |
| EEG studies | Whether gamma entrainment occurs |
| Blood biomarkers | Possible changes in disease-related biology |
| Brain imaging | Possible structural or functional changes |
| Cognitive testing | Possible effects on cognition |
| Large randomized trials | Whether the intervention actually works clinically |
The last category is the most important for determining whether 40Hz stimulation should ultimately be considered an effective Alzheimer's treatment.
40Hz Light Is Not the Same as Every Type of 40Hz Stimulation
Another important point is that 40Hz describes frequency, not the type of stimulation.
Researchers have investigated several approaches, including:
-
40Hz visual light stimulation
-
40Hz auditory stimulation
-
Combined visual and auditory stimulation
-
Electrical stimulation such as 40Hz tACS
-
Other experimental forms of sensory stimulation
These approaches should not automatically be treated as equivalent.
For example, 40Hz tACS uses electrical stimulation, whereas 40Hz visual stimulation uses patterned light.
A positive result from one modality cannot automatically be used as proof for another.
This is particularly important when evaluating products marketed as 40Hz light therapy glasses.
What About 40Hz Light Therapy Glasses?
Consumer 40Hz glasses may use light that is modulated at approximately 40Hz.
Conceptually, this is related to the visual stimulation methods studied in neuroscience research.
However, the exact characteristics of a research system can vary significantly from those of a consumer product.
Important variables can include:
-
Light intensity
-
Optical output
-
Flicker characteristics
-
Modulation depth
-
Exposure duration
-
Distance from the eyes
-
Stimulation schedule
-
Device geometry
-
Whether auditory stimulation is included
-
Whether EEG entrainment has been independently measured
Therefore, a consumer 40Hz product should not automatically be considered equivalent to a clinical research device.
The scientific literature supports studying 40Hz sensory stimulation. It does not mean that every device using the label “40Hz” has been clinically validated for Alzheimer's disease.
Could 40Hz Stimulation Eventually Affect Alzheimer's Pathology?
It is possible, but researchers do not yet know.
The most interesting hypothesis is that repeated gamma stimulation may influence several interconnected biological systems rather than acting on only one protein.
Researchers are investigating possible relationships among:
Gamma oscillations
→ neural synchronization
→ neuronal activity
→ vascular and immune responses
→ protein clearance
→ amyloid and tau biology
→ synaptic function
→ cognition
This is one reason the field has attracted significant attention.
But it is also why more research is necessary.
Alzheimer's disease is biologically complex, and amyloid and tau are only parts of a much larger disease process.
Why Larger Clinical Trials Matter
Small pilot studies are useful for discovering signals.
They can help researchers answer questions such as:
-
Is the stimulation feasible?
-
Is it tolerated?
-
Does it produce gamma entrainment?
-
Do biomarkers change?
-
What stimulation schedule should be tested?
But small studies cannot reliably determine whether a treatment produces meaningful clinical benefits.
Larger randomized controlled trials can help determine whether observed changes are caused by the intervention rather than:
-
Natural variation
-
Placebo effects
-
Selection bias
-
Regression to the mean
-
Differences in adherence
-
Other treatments
-
Statistical chance
This is why several ongoing studies are investigating 40Hz stimulation with more rigorous designs.
For example, a 2026 ClinicalTrials.gov study plans to enroll 90 participants with amyloid-PET-positive Alzheimer's disease and compare fixed 40Hz audiovisual stimulation, individualized stimulation guided by EEG, and sham stimulation over six months.
These types of trials could provide much stronger evidence.
40Hz, Amyloid and Tau: Where the Science Stands
The current evidence can be summarized in four levels.
Stronger evidence
40Hz sensory stimulation can influence neural activity and produce gamma-frequency entrainment under appropriate experimental conditions.
Promising preclinical evidence
Animal studies suggest that gamma stimulation can influence amyloid, tau, synaptic function, and other Alzheimer's-related biological processes.
Early human evidence
Small human studies are beginning to report changes in biomarkers associated with amyloid and tau.
What remains unproven
It has not yet been established that 40Hz light stimulation can remove Alzheimer's plaques, reverse tau pathology, prevent Alzheimer's disease, or treat Alzheimer's disease.
That distinction is critical.
The Bottom Line
So, can 40Hz stimulation affect amyloid and tau?
The most accurate answer is:
Research suggests that it may.
Animal studies provide evidence that 40Hz gamma stimulation can influence amyloid- and tau-related pathways. Early human research has also reported exploratory changes in blood biomarkers following 40Hz light stimulation.
However, the human evidence is still limited.
The 2026 biomarker study was small, and broader systematic-review evidence has not yet established a consistent improvement in cognition or daily functioning.
Therefore, 40Hz stimulation should currently be understood as an emerging area of neuroscience and Alzheimer's research, rather than a proven treatment for Alzheimer's disease.
As larger randomized clinical trials are completed, researchers will be better able to determine whether changes in gamma activity and biomarkers translate into meaningful improvements in memory, cognition, brain health, and disease progression.
Frequently Asked Questions
Does 40Hz stimulation remove amyloid plaques?
There is currently no conclusive human evidence showing that 40Hz stimulation removes Alzheimer's amyloid plaques. Animal research has reported reductions in amyloid pathology, while early human studies are examining related biomarkers.
Can 40Hz stimulation reduce tau?
Preclinical studies suggest that 40Hz stimulation may influence tau phosphorylation. A small 2026 human study also reported reductions in plasma p-tau217, but larger controlled studies are needed to determine whether this finding is reproducible and clinically meaningful.
What is 40Hz gamma stimulation?
40Hz gamma stimulation refers to sensory or neuromodulatory stimulation delivered at a frequency of approximately 40 cycles per second. Visual stimulation, auditory stimulation, combined audiovisual stimulation, and electrical stimulation have all been investigated.
Is 40Hz light the same as 670nm red light?
No.
40Hz describes temporal modulation frequency, while 670nm describes optical wavelength.
A light source can have a 670nm wavelength while being modulated at a particular frequency, but these describe different properties of light.
Is 40Hz light therapy proven to treat Alzheimer's disease?
No. Current evidence is promising but preliminary. 40Hz stimulation remains an active research area, and larger controlled clinical trials are needed before its effectiveness for Alzheimer's disease can be established.
Are 40Hz glasses the same as devices used in clinical studies?
Not necessarily. Research devices can differ substantially in light intensity, modulation, exposure schedule, stimulation geometry, and other technical parameters. A consumer product using 40Hz should not automatically be considered clinically equivalent to a research device.
Why are amyloid and tau important in Alzheimer's research?
Amyloid beta accumulation and abnormal tau are two major biological features studied in Alzheimer's disease. Researchers investigate them because changes in these proteins and their associated biomarkers can provide information about disease biology and potential treatment mechanisms.
A Research-Based Perspective
Interest in 40Hz light stimulation, gamma entrainment, amyloid beta, and tau has grown rapidly because the research connects neuroscience, brain network activity, and Alzheimer's disease biology in a potentially new way.
The most important development is not a single study claiming that 40Hz has solved Alzheimer's disease.
Instead, it is the growing body of research asking whether modulating brain rhythms can influence biological processes associated with neurodegeneration.
That question remains open.
And as more rigorous human studies become available, researchers will have a clearer answer to whether 40Hz gamma stimulation represents a meaningful new approach to brain health and Alzheimer's research.
LUMVOO Journal will continue to follow the emerging science as new clinical and neuroscience research becomes available.
Selected Research
-
Chou PS, Chien CF, Huang LC, Yang YH. Therapeutic effects of 40 Hz light stimulation on clinical and pathological features of Alzheimer's disease. Dialogues in Clinical Neuroscience, 2026.
-
Ang S, et al. The safety and efficacy of gamma frequency auditory and visual stimulation in the treatment of Alzheimer's disease: a systematic review and meta-analysis. Translational Psychiatry, 2025.
-
Research progress on 40 Hz sensory stimulation for the treatment of Alzheimer's disease. Frontiers in Aging Neuroscience, 2025.
-
Gamma oscillation modulation for cognitive impairment: A systematic review. Journal of Alzheimer's Disease, 2025.
Disclaimer: This article is for educational and informational purposes only. It summarizes emerging scientific research and does not constitute medical advice or establish 40Hz light stimulation as a treatment, cure, or prevention method for Alzheimer's disease or any other medical condition.